Free Trial
NASDAQ:ASTH

Astrana Health (ASTH) Stock Price, News & Analysis

Astrana Health logo
$24.49 -0.63 (-2.51%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$24.84 +0.35 (+1.43%)
As of 07/15/2025 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Astrana Health Stock (NASDAQ:ASTH)

Key Stats

Today's Range
$24.36
$25.49
50-Day Range
$24.00
$33.44
52-Week Range
$23.12
$63.20
Volume
367,050 shs
Average Volume
295,410 shs
Market Capitalization
$1.37 billion
P/E Ratio
34.01
Dividend Yield
N/A
Price Target
$53.29
Consensus Rating
Moderate Buy

Company Overview

Astrana Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

ASTH MarketRank™: 

Astrana Health scored higher than 74% of companies evaluated by MarketBeat, and ranked 273rd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Astrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Astrana Health has received no research coverage in the past 90 days.

  • Read more about Astrana Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Astrana Health is 34.01, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Astrana Health is 34.01, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.52.

  • Price to Earnings Growth Ratio

    Astrana Health has a PEG Ratio of 0.92. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Astrana Health has a P/B Ratio of 1.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Astrana Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.85% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Astrana Health has recently decreased by 2.72%, indicating that investor sentiment is improving.
  • Dividend Yield

    Astrana Health does not currently pay a dividend.

  • Dividend Growth

    Astrana Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.85% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Astrana Health has recently decreased by 2.72%, indicating that investor sentiment is improving.
  • News Sentiment

    Astrana Health has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Astrana Health this week, compared to 5 articles on an average week.
  • Search Interest

    6 people have searched for ASTH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Astrana Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Astrana Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.46% of the stock of Astrana Health is held by insiders.

  • Percentage Held by Institutions

    52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Astrana Health's insider trading history.
Receive ASTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter.

ASTH Stock News Headlines

All New Social Security Numbers coming July 23?
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.
See More Headlines

ASTH Stock Analysis - Frequently Asked Questions

Astrana Health's stock was trading at $31.53 on January 1st, 2025. Since then, ASTH shares have decreased by 22.3% and is now trading at $24.49.

Astrana Health, Inc. (NASDAQ:ASTH) issued its quarterly earnings data on Thursday, May, 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by $0.09. The company's revenue was up 53.4% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of Astrana Health include Westmount Partners LLC (0.15%).

Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
5/08/2025
Today
7/16/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Business Services
Current Symbol
NASDAQ:ASTH
Previous Symbol
NASDAQ:ASTH
CIK
1083446
Employees
1,900
Year Founded
N/A

Price Target and Rating

High Price Target
$70.00
Low Price Target
$36.00
Potential Upside/Downside
+117.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.72
Trailing P/E Ratio
34.01
Forward P/E Ratio
21.30
P/E Growth
0.92
Net Income
$43.15 million
Net Margins
1.56%
Pretax Margin
2.95%
Return on Equity
4.90%
Return on Assets
2.68%

Debt

Debt-to-Equity Ratio
0.54
Current Ratio
1.70
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$2.03 billion
Price / Sales
0.67
Cash Flow
$1.45 per share
Price / Cash Flow
16.92
Book Value
$14.59 per share
Price / Book
1.68

Miscellaneous

Outstanding Shares
56,060,000
Free Float
51,319,000
Market Cap
$1.37 billion
Optionable
Optionable
Beta
0.84
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ASTH) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners